UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 163

Sortiert nach

Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients

Clinical infectious diseases, 2012-01, Vol.54 (1), p.96-104

2012

Link zum Volltext

Verfügbarkeit prüfen

Amphotericin B: Time for a New “Gold Standard”

Clinical infectious diseases, 2003-08, Vol.37 (3), p.415-425

2003

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir: The First HIV Type 1 Integrase Inhibitor

Clinical infectious diseases, 2009-04, Vol.48 (7), p.931-939

2009

Link zum Volltext

Verfügbarkeit prüfen

Review of Hepatitis B Therapeutics

Clinical infectious diseases, 2010-11, Vol.51 (10), p.1201-1208

2010

Link zum Volltext

Verfügbarkeit prüfen

Anidulafungin: A Novel Echinocandin

Clinical infectious diseases, 2006-07, Vol.43 (2), p.215-222

2006

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin: Another Novel Agent for Treating Infections Due to Drug-Resistant Gram-Positive Pathogens

Clinical infectious diseases, 2004-04, Vol.38 (7), p.994-1000

2004

Link zum Volltext

Verfügbarkeit prüfen

Micafungin: A New Echinocandin

Clinical infectious diseases, 2006-04, Vol.42 (8), p.1171-1178

2006

Link zum Volltext

Verfügbarkeit prüfen

Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus

Clinical infectious diseases, 2015-03, Vol.60 (5), p.787-796

2015

Link zum Volltext

Verfügbarkeit prüfen

Caspofungin

Clinical infectious diseases, 2003-06, Vol.36 (11), p.1445-1457

2003

Link zum Volltext

Verfügbarkeit prüfen

New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage

Clinical infectious diseases, 2006-10, Vol.43 (8), p.1060-1068

2006

Link zum Volltext

Verfügbarkeit prüfen

Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice

Clinical infectious diseases, 2015-11, Vol.61 (9), p.1446-1452

2015

Link zum Volltext

Verfügbarkeit prüfen

Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era

Clinical infectious diseases, 2012-09, Vol.55 (6), p.860-867

2012

Link zum Volltext

Verfügbarkeit prüfen

Doripenem

Clinical infectious diseases, 2009-07, Vol.49 (2), p.291-298

2009

Link zum Volltext

Verfügbarkeit prüfen

EDITORIAL COMMENTARY: Double Gram-Positive Coverage for Acute Bacterial Skin and Skin Structure Infections: Has the Eagle Landed?

Clinical infectious diseases, 2015-10, Vol.61 (7), p.1155-1156

2015

Link zum Volltext

Verfügbarkeit prüfen

Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections

Clinical infectious diseases, 2015-10, Vol.61 (7), p.1148-1154

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates

Clinical infectious diseases, 2012-08, Vol.55 (4), p.582-586

2012

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection

Clinical infectious diseases, 2014-07, Vol.59 (2), p.265-271

2014

Link zum Volltext

Verfügbarkeit prüfen

The Antimicrobial Therapy Puzzle: Could Pharmacokinetic-Pharmacodynamic Relationships Be Helpful in Addressing the Issue of Appropriate Pneumonia Treatment in Critically Ill Patients?

Clinical infectious diseases, 2006-06, Vol.42 (12), p.1764-1771

2006

Link zum Volltext

Verfügbarkeit prüfen

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic

Clinical infectious diseases, 2008-02, Vol.46 (4), p.577-583

2008

Link zum Volltext

Verfügbarkeit prüfen

Miconazole Mucoadhesive Tablets: A Novel Delivery System

Clinical infectious diseases, 2012-05, Vol.54 (10), p.1480-1484

2012

Link zum Volltext

Verfügbarkeit prüfen

Fluoroquinolones and Anaerobes

Clinical infectious diseases, 2006-06, Vol.42 (11), p.1598-1607

2006

Link zum Volltext

Verfügbarkeit prüfen

The Quad Pill, a Once-Daily Combination Therapy for HIV Infection

Clinical infectious diseases, 2014-01, Vol.58 (1), p.93-98

2014

Link zum Volltext

Verfügbarkeit prüfen

Quinupristin-Dalfopristin and Linezolid: Evidence and Opinion

Clinical infectious diseases, 2003-02, Vol.36 (4), p.473-481

2003

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir Disoproxil Fumarate

Clinical infectious diseases, 2003-10, Vol.37 (7), p.944-950

2003

Link zum Volltext

Verfügbarkeit prüfen

Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus

Clinical infectious diseases, 2006-01, Vol.42 (1), p.126-131

2006

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 163

Suche als RSS-Feed

Aktive Filter

ThemaAntimicrobial

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(163)

Sprache

Englisch
(163)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(152)
Science & Technology
(152)
Humans
(146)
Microbiology
(114)
Infectious Diseases
(113)
Immunology
(89)
Biological And Medical Sciences
(74)
Medical Sciences
(71)
Reviews Of Anti-Infective Agents
(59)
Infections
(57)
Anti-Infective Agents - Therapeutic Use
(52)
Pharmacology. Drug Treatments
(50)
Dosage
(48)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(47)
Antibiotics
(43)
Pharmacology & Pharmacy
(37)
Antibacterial Agents
(30)
Antimicrobials
(27)
Anti-Bacterial Agents - Therapeutic Use
(25)
Drug Resistance
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients

Amphotericin B: Time for a New “Gold Standard”

Raltegravir: The First HIV Type 1 Integrase Inhibitor

Review of Hepatitis B Therapeutics

Anidulafungin: A Novel Echinocandin

Daptomycin: Another Novel Agent for Treating Infections Due to Drug-Resistant Gram-Positive Pathogens

Micafungin: A New Echinocandin

Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus

Caspofungin

New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage

Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice

Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era

Doripenem

EDITORIAL COMMENTARY: Double Gram-Positive Coverage for Acute Bacterial Skin and Skin Structure Infections: Has the Eagle Landed?

Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections

In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates

Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection

The Antimicrobial Therapy Puzzle: Could Pharmacokinetic-Pharmacodynamic Relationships Be Helpful in Addressing the Issue of Appropriate Pneumonia Treatment in Critically Ill Patients?

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic

Miconazole Mucoadhesive Tablets: A Novel Delivery System

Fluoroquinolones and Anaerobes

The Quad Pill, a Once-Daily Combination Therapy for HIV Infection

Quinupristin-Dalfopristin and Linezolid: Evidence and Opinion

Tenofovir Disoproxil Fumarate

Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus

Aktive Filter

Suchergebnisse filtern